1 year return (CAGR)
45.91%
ArriVent BioPharma, Inc. Common Stock Exchange (NASDAQ, USD)
AVBP
27.65
-0.32 (-1.14%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.36B
Price/Sales
-
Ent value
1.24B
Price/Book
3.72
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 28.15 |
| Daily high | 28.30 |
| Daily low | 27.29 |
| Daily Volume | 379K |
| All-time high | 35.63 |
| 1y analyst estimate | 44.70 |
| Beta | 1.37 |
| EPS (TTM) | -3.44 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AVBP | S&P500 | |
| Current price drop from All-time high | -22.40% | -3.06% |
| Highest price drop | -54.25% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -25.98% | -10.68% |
| Avg time to new high | 28 days | 12 days |
| Max time to new high | 464 days | 1805 days |
News
